Cargando…
Hypercalcemia after the Discontinuation of Medroxyprogesterone Acetate
A 39-year-old woman was admitted to our hospital with symptoms of general fatigue, nausea, and vomiting that appeared three months after she stopped seven years of medroxyprogesterone acetate (MPA) medication for endometrial stromal sarcoma. Laboratory tests demonstrated moderate hypercalcemia. Seve...
Autores principales: | Yuasa-Shibasaki, Erina, Ishii, Sumiyasu, Matsumoto, Shunichi, Tomaru, Takuya, Horiguchi, Kazuhiko, Osaki, Aya, Ozawa, Atsushi, Shibusawa, Nobuyuki, Satoh, Tetsurou, Yamada, Masanobu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5849551/ https://www.ncbi.nlm.nih.gov/pubmed/29225247 http://dx.doi.org/10.2169/internalmedicine.9036-17 |
Ejemplares similares
-
Adrenal Ewing's Sarcoma in an Elderly Man
por: Toda, Kazuyoshi, et al.
Publicado: (2017) -
Transcriptional Regulation of the Angptl8 Gene by Hepatocyte Nuclear Factor-1 in the Murine Liver
por: Watanabe, Takuya, et al.
Publicado: (2020) -
NR4A1 (Nur77) Mediates Thyrotropin-Releasing Hormone-Induced Stimulation of Transcription of the Thyrotropin β Gene: Analysis of TRH Knockout Mice
por: Nakajima, Yasuyo, et al.
Publicado: (2012) -
Identification of a Long Non-Coding RNA Derived From the Antisense Strand of the Thyroid Hormone Receptor Beta Gene
por: Ishii, Sumiyasu, et al.
Publicado: (2021) -
Medroxyprogesterone acetate levels among Kenyan women using depot medroxyprogesterone acetate in the FEM-PrEP trial()()
por: Nanda, Kavita, et al.
Publicado: (2016)